Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controll... by Xu, Binghe, Prof, Yan, Min, Prof, Ma, Fei, Prof, Hu, Xichun, Prof, Feng, Jifeng, Prof, Ouyang, Quchang, Prof, Tong, Zhongsheng, Prof, Li, Huiping, Prof, Zhang, Qingyuan, Prof, Sun, Tao, Prof, Wang, Xian, MD, Yin, Yongmei, Prof, Cheng, Ying, Prof, Li, Wei, Prof, Gu, Yuanting, Prof, Chen, Qianjun, Prof, Liu, Jinping, Prof, Cheng, Jing, Prof, Geng, Cuizhi, Prof, Qin, Shukui, Prof, Wang, Shusen, Prof, Lu, Jinsong, Prof, Shen, Kunwei, Prof, Liu, Qiang, Prof, Wang, Xiaojia, Prof, Wang, Hong, Prof, Luo, Ting, Prof, Yang, Jin, Prof, Wu, Yudong, Prof, Yu, Zhiyong, Prof, Zhu, Xiaoyu, MD, Chen, Chunxia, MSc, Zou, Jianjun, MD

Get full text